Muscle Biology
1 – 50 of 86
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Thrombospondin-4 deletion does not exacerbate muscular dystrophy in β-sarcoglycan-deficient and laminin α2 chain-deficient mice
(
- Contribution to journal › Article
- 2023
-
Mark
Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration
(
- Contribution to journal › Article
- 2022
-
Mark
Skeletal muscle regeneration is altered in the R6/2 mouse model of Huntington’s disease
2022) p.1-23(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Editorial : Extracellular matrix in homeostasis and cancer
(
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
Isolated lumbar extension resistance exercise in limited range of motion for patients with lumbar radiculopathy and disk herniation—clinical outcome and influencing factors
(
- Contribution to journal › Article
-
Mark
A guide to the composition and functions of the extracellular matrix
(
- Contribution to journal › Article
-
Mark
Clinical and Molecular Spectrum Associated with COL6A3 c.7447A>G p.(Lys2483Glu) Variant : Elucidating its Role in Collagen VI-related Myopathies
(
- Contribution to journal › Article
-
Mark
A novel COL1A1 variant in a family with clinical features of hypermobile Ehlers-Danlos syndrome that proved to be a COL1-related overlap disorder
(
- Contribution to journal › Article
-
Mark
Merosin deficient congenital muscular dystrophy type 1A : An international workshop on the road to therapy 15-17 November 2019, Maastricht, the Netherlands
(
- Contribution to journal › Article
- 2020
-
Mark
Antioxidants reduce muscular dystrophy in the dy2J/dy2J mouse model of laminin α2 chain-deficient muscular dystrophy
(
- Contribution to journal › Article
-
Mark
A Family of Laminin α2 Chain-Deficient Mouse Mutants : Advancing the Research on LAMA2-CMD
(
- Contribution to journal › Scientific review
- 2019
-
Mark
A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene
(
- Contribution to journal › Letter
-
Mark
Effects of N-acetyl-L-cysteine and vitamin E on congenital muscular dystrophy type 1A disease progression in mice
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2018
-
Mark
Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study
2018) In Scientific Reports(
- Contribution to journal › Article
-
Mark
Laminin α1 reduces muscular dystrophy in dy2Jmice
(
- Contribution to journal › Article
-
Mark
Potential therapies and biomarkers for LAMA2-CMD. Does the microRNA hype deliver?
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Exploratory Profiling of Urine MicroRNAs in the dy2J/dy2J Mouse Model of LAMA2-CMD : Relation to Disease Progression
(
- Contribution to journal › Article
- 2017
-
Mark
Potent pro-inflammatory and profibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chaindeficient muscular dystrophy
(
- Contribution to journal › Article
-
Mark
Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells
(
- Contribution to journal › Article
-
Mark
Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD
(
- Contribution to journal › Article
- 2016
-
Mark
Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
(
- Contribution to journal › Article
-
Mark
Skeletal muscle wasting and renewal : a pivotal role of myokine IL-6
(
- Contribution to journal › Scientific review
-
Mark
Congenital muscular dystrophy with laminin α2 chain-deficiency. Initiation of disease and development of treatment
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Update on hereditary colorectal cancer
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice.
(
- Contribution to journal › Article
-
Mark
Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment.
(
- Contribution to journal › Article
-
Mark
Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice.
(
- Contribution to journal › Article
- 2014
-
Mark
Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma.
(
- Contribution to journal › Article
-
Mark
Fibrin binds to collagen and provides a bridge for alpha V beta 3 integrin-dependent contraction of collagen gels
(
- Contribution to journal › Article
-
Mark
Bortezomib Partially Improves Laminin α2 Chain-Deficient Muscular Dystrophy.
(
- Contribution to journal › Article
-
Mark
Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.
(
- Contribution to journal › Article
-
Mark
Loss of Dystrophin and β-Sarcoglycan, Respectively, Significantly Exacerbates the Phenotype of Laminin α2 Chain-Deficient Animals.
(
- Contribution to journal › Article
-
Mark
Caracterización molecular de cáncer colorrectal hereditario en Perú
2014) In Revista de gastroenterología del Perú : órgano oficial de la Sociedad de Gastroenterología del Perú 34(4). p.299-303(
- Contribution to journal › Article
- 2013
-
Mark
Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of Dystrophy
(
- Contribution to journal › Article
-
Mark
Evaluation of macroporous blood and plasma scaffolds for skeletal muscle tissue engineering
(
- Contribution to journal › Article
-
Mark
Mutation spectrum in South American Lynch syndrome families
(
- Contribution to journal › Article
- 2012
-
Mark
Increased Neointimal Thickening in Dystrophin-Deficient mdx Mice.
(
- Contribution to journal › Article
-
Mark
Laminin-211 in skeletal muscle function.
(
- Contribution to journal › Article
-
Mark
Cell-matrix interactions in muscle disease.
(
- Contribution to journal › Article
-
Mark
Oxidized Dextran as Crosslinker for Chitosan Cryogel Scaffolds and Formation of Polyelectrolyte Complexes between Chitosan and Gelatin.
(
- Contribution to journal › Article
-
Mark
Porous protein-based scaffolds prepared through freezing as potential scaffolds for tissue engineering.
(
- Contribution to journal › Article
-
Mark
Guidelines for the use and interpretation of assays for monitoring autophagy
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Transgenic Expression of Laminin α1 Chain Does Not Prevent Muscle Disease in the mdx Mouse Model for Duchenne Muscular Dystrophy.
(
- Contribution to journal › Article
-
Mark
Autophagy is increased in laminin {alpha}2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A.
(
- Contribution to journal › Article
-
Mark
Proteasome Inhibition Improves the Muscle of Laminin {alpha}2 Chain Deficient Mice.
(
- Contribution to journal › Article
-
Mark
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies.
(
- Contribution to journal › Article
-
Mark
Laminin isoforms in atherosclerotic arteries from mice and man.
(
- Contribution to journal › Article
- 2010
-
Mark
Transgenic overexpression of laminin 1 chain in laminin 2 chain-deficient mice rescues the disease throughout the lifespan
(
- Contribution to journal › Article
-
Mark
Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency.
(
- Contribution to journal › Article
-
Mark
Laminins.
(
- Contribution to journal › Article